151 related articles for article (PubMed ID: 32510753)
1. MeCP2 inhibits proliferation and migration of breast cancer via suppression of epithelial-mesenchymal transition.
Jiang W; Liang YL; Liu Y; Chen YY; Yang ST; Li BR; Yu YX; Lyu Y; Wang R
J Cell Mol Med; 2020 Jul; 24(14):7959-7967. PubMed ID: 32510753
[TBL] [Abstract][Full Text] [Related]
2. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
Bian E; Chen X; Xu Y; Ji X; Cheng M; Wang H; Fang Z; Zhao B
J Exp Clin Cancer Res; 2019 Aug; 38(1):366. PubMed ID: 31429770
[TBL] [Abstract][Full Text] [Related]
3. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
[TBL] [Abstract][Full Text] [Related]
4. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 overexpression inhibits proliferation, migration and invasion of C6 glioma by modulating ERK signaling and gene expression.
Sharma K; Singh J; Frost EE; Pillai PP
Neurosci Lett; 2018 May; 674():42-48. PubMed ID: 29540297
[TBL] [Abstract][Full Text] [Related]
8. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.
Xia B; Hou L; Kang H; Chang W; Liu Y; Zhang Y; Ding Y
BMC Cancer; 2020 Jul; 20(1):626. PubMed ID: 32631390
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
10. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
Li Y; Su X; Pan H
Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
13. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
Duan S; Luo X; Zeng H; Zhan X; Yuan C
Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152
[TBL] [Abstract][Full Text] [Related]
14. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
16. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
17. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
18. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
19. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 promotes endothelial-to-mesenchymal transition in human endothelial cells by downregulating BMP7 expression.
Li Z; Song S; Zha S; Wang C; Chen S; Wang F
Exp Cell Res; 2019 Feb; 375(1):82-89. PubMed ID: 30597142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
